Shun Xin Wang Lin

Teclistamab in Relapsed or Refractory Multiple Myeloma

Philippe Moreau, Alfred L. Garfall, Niels W.C.J. van de Donk et al. · New England Journal of Medicine · 2022 · 1.1K citations · Full text

Medicine, Hematology, Immunology +17

The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies

Shun Xin Wang Lin, Ruth Olson, Janet M. Beanan et al. · Infection and Immunity · 2017 · 63 citations

Pharmacy, Infectious Diseases, Microbiology +17

Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study

Diana Cortés‐Selva, Tatiana Perova, Sheri Skerget et al. · Blood · 2024 · 53 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma

Suzette Girgis, Shun Xin Wang Lin, Kodandaram Pillarisetti et al. · Blood Advances · 2022 · 49 citations · Full text

Medicine, Hematology, Pharmacology +14

Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies

Cyrille Touzeau, Amrita Krishnan, Philippe Moreau et al. · Blood · 2024 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17